MedPath

Orphenadrine Citrate

Orphenadrine Citrate Extended-Release Tablets

Approved
Approval ID

34769dda-f555-460e-9064-98ab205393c5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 22, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Orphenadrine Citrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-099
Application NumberANDA040284
Product Classification
M
Marketing Category
C73584
G
Generic Name
Orphenadrine Citrate
Product Specifications
Route of AdministrationORAL
Effective DateNovember 20, 2009
FDA Product Classification

INGREDIENTS (4)

ORPHENADRINE CITRATEActive
Quantity: 100 mg in 1 1
Code: X0A40N8I4S
Classification: ACTIB
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Orphenadrine Citrate - FDA Drug Approval Details